Literature DB >> 2757043

Streamlining antimicrobial therapy through pharmacists' review of order sheets.

L L Briceland1, T S Lesar, B M Lomaestro, T P Lombardi, R A Gailey, S F Kowalsky.   

Abstract

The impact of a pharmacy-conducted intervention program designed to contain costs by "streamlining" antimicrobial therapy is described. Streamlining of antimicrobial therapy may involve simplifying routes of administration, decreasing the dose or frequency of antimicrobial administration, or converting from multiple-agent therapy to single-agent therapy. Beginning on December 1, 1987, pharmacists at this university-affiliated teaching hospital used the antimicrobial order sheet (AOS) filled out by all prescribers of anti-infective agents to identify orders that were potential candidates for streamlining. Interventions involved a discussion between the pharmacist and prescriber in which the pharmacist specified the reasoning behind the recommended change. For each recommendation that was accepted by the prescriber, the cost savings per day was determined by subtracting the daily cost of the recommended streamlined therapy from the daily cost of the original "problem" therapy. Data collection continued until May 1, 1988. During that five-month period, 162 out of 173 pharmacist-initiated streamlining recommendations were accepted by prescribers, resulting in a total cost savings of $19,864. The average cost savings per intervention was $122.62. The most frequent intervention involved decreasing the frequency of i.v. administration, decreasing the dose, or both. The intervention that resulted in the greatest average cost savings involved simplifying the route of administration or discontinuing antimicrobial therapy entirely. The projected annual cost savings of this program is $47,700. By using information from AOSs to identify problem antimicrobial orders, pharmacists were able to recommend streamlining of antimicrobial therapies that resulted in an average cost savings of about $122 per intervention.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2757043

Source DB:  PubMed          Journal:  Am J Hosp Pharm        ISSN: 0002-9289


  4 in total

1.  Sequential antimicrobial therapy: a realistic approach to cost containment?

Authors:  D R Guay
Journal:  Pharmacoeconomics       Date:  1993-05       Impact factor: 4.981

2.  Strategies for controlling antibiotic use in a tertiary-care paediatric hospital.

Authors:  S A Diamond; B J Hales
Journal:  Paediatr Child Health       Date:  1997-05       Impact factor: 2.253

Review 3.  Drug utilisation review (DUR) of the third generation cephalosporins. Focus on ceftriaxone, ceftazidime and cefotaxime.

Authors:  A Adu; C L Armour
Journal:  Drugs       Date:  1995-09       Impact factor: 9.546

4.  Modifying provider behavior: a low-tech approach to pharmaceutical ordering.

Authors:  Jeffrey J Guterman; Bruce A Chernof; Beatriz Mares; Sandra G Gross-Schulman; Pramod G Gan; Donald Thomas
Journal:  J Gen Intern Med       Date:  2002-10       Impact factor: 5.128

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.